Diagnostic Kits/Paper: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
==== Brief History of GDx and Related Technology ==== | ==== Brief History of GDx and Related Technology ==== | ||
* chemical patents at turn of century (see Palombi's work) | |||
==== Overview of IP Landscape === | |||
=== | ==== When IP Does and Does Not Work Effectively ==== | ||
=== Our Research Questions === | === Our Research Questions === | ||
| Line 27: | Line 28: | ||
== Forces affecting the GDx Industry == | == Forces affecting the GDx Industry == | ||
* Technical advances | |||
Revision as of 12:35, 3 December 2009
Are patents clogging the pipeline: The effects of intellectual property on commercialization and access to genetic diagnostics
(A Summary Paper of our Research to date)
By Carolina Rossini, Andrew Clearwater, and Mackenzie Cowell
Last Draft: December 3, 2009
Introduction
Description of the GDx Market
Defining Genetic Diagnostics
Brief History of GDx and Related Technology
- chemical patents at turn of century (see Palombi's work)
= Overview of IP Landscape
When IP Does and Does Not Work Effectively
Our Research Questions
Our Methodology
Forces affecting the GDx Industry
- Technical advances